Hostname: page-component-cc8bf7c57-77pjf Total loading time: 0 Render date: 2024-12-09T11:07:01.978Z Has data issue: false hasContentIssue false

An in vivo appraisal of Punica granatum peel extract’s ultrastructural effect on cystic echinococcosis in mice

Published online by Cambridge University Press:  13 May 2024

Nashaat E. Nassef
Affiliation:
Parasitology Department, Faculty of Medicine, Menoufia University, Yassin Abdel Ghaffar St. from Gamal Abdel Nasser St., Shebin El-Kom, Menoufia, Egypt
Sawsan S. Shendi
Affiliation:
Department of Clinical and Molecular Parasitology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt
Abdel-Gawad E. Saad
Affiliation:
Department of Clinical and Molecular Parasitology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt
Nancy M. Harba
Affiliation:
Parasitology Department, Faculty of Medicine, Menoufia University, Yassin Abdel Ghaffar St. from Gamal Abdel Nasser St., Shebin El-Kom, Menoufia, Egypt
Engy V.N. Beshay
Affiliation:
Parasitology Department, Faculty of Medicine, Menoufia University, Yassin Abdel Ghaffar St. from Gamal Abdel Nasser St., Shebin El-Kom, Menoufia, Egypt
Asmaa Shams El-Dein Mohamed
Affiliation:
Pathology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt
Marwa A. Gouda*
Affiliation:
Department of Clinical and Molecular Parasitology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Menoufia, Egypt
*
Corresponding author: Marwa A. Gouda; Email: marwa_goda@liver.menofia.edu.eg
Rights & Permissions [Opens in a new window]

Abstract

In the past decade, interest has significantly increased regarding the medicinal and nutritional benefits of pomegranate (Punica granatum) peel. This study examined the effects of using pomegranate peel extract (PGE) alone and in combination with albendazole (ABZ) on ultrastructural and immunological changes in cystic echinococcosis in laboratory-infected mice. Results revealed that the smallest hydatid cyst size and weight (0.48 ± 0.47mm, 0.17 ± 0.18 gm) with the highest drug efficacy (56.2%) was detected in the PGE + ABZ group, which also exhibited marked histopathological improvement. Ultrastructural changes recorded by transmission electron microscopy including fragmentation of the nucleus, glycogen depletion, and multiple lysosomes in vacuolated cytoplasm were more often observed in PGE + ABZ group. IFN-γ levels were significantly increased in the group treated with ABZ, with a notable reduction following PGE treatment, whether administered alone or in combination with ABZ. Thus, PGE enhanced the therapeutic efficiency of ABZ, with improvement in histopathological and ultrastructural changes.

Type
Research Paper
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Introduction

Cystic echinococcosis (CE) is a widely distributed parasitic disease resulting from the hydatid cyst caused by Echinococcus granulosus. It is also known as hydatid disease or hydatidosis and is classified as a zoonotic illness (Kern et al. Reference Kern, Menezes da Silva, Akhan, Müllhaupt, Vizcaychipi, Budke and Vuitton2017). Echinococcosis has been considered among the 20 neglected tropical diseases targeted by the WHO for disease eradication or control (Abdelbaset et al. Reference Abdelbaset, Yagi, Nonaka and Nakao2021; WHO 2022).

More than one million people contract echinococcosis globally each year. The cost of treating patients with echinococcosis and damage to the livestock industry is about three billion dollars (Mahmoudi et al. Reference Mahmoudi, Mamishi, Banar, Pourakbari and Keshavarz2019). Humans become infected by ingestion of ova accidentally through direct contact with dogs or indirect contact with contaminated food, soil, or water (Jelowdar et al. Reference Jelowdar, Rafiei, Abbaspour, Rashidi and Rahdar2017). Although various organs of CE patients may be invaded by the oncosphere, approximately 70% of patients are affected in the liver and approximately 20% are affected in the lungs (Wen et al. Reference Wen, Vuitton, Tuxun, Li, Vuitton, Zhang and McManus2019). The location, size, and number of cysts, affected organs, oxidative stress, and the immune responses of infected individuals play important roles in the pathogenesis and clinical signs of echinococcosis (Heidarpour et al. Reference Heidarpour, Mohri, Borji and Moghdass2012).

Although surgery is the primary treatment method, leakage of cystic fluid is the primary cause of infection recurrence. Therefore, it is mandatory to kill the protoscoleces within the cyst during the surgical procedure (Shi et al. Reference Shi, Lei, Wang, Wang, Xing, Lv and Jiang2016). Benzimidazoles such as albendazole (ABZ) are common medications to treat human infections, but such drugs are known to have parasitostatic rather than parasiticidal effects. Moreover, the low water solubility and low absorption of benzimidazoles may be responsible for ineffective treatment (Siles-Lucas et al. Reference Siles-Lucas, Casulli, Cirilli and Carmena2018). Therefore, researchers have made several attempts to increase these compounds’ solubility, absorption, and bioavailability by finding new effective compounds for the treatment of cystic echinococcosis. Plant-based anthelmintics have been used for the treatment of many parasitic diseases, including echinococcosis (Atayi et al. Reference Atayi, Borji, Moazeni, Saboor Darbandi and Heidarpour2018). Pomegranate (Punica granatum), a well-known edible fruit, is a member of the family Punicaceae and is widely known for the tremendous medicinal properties conferred by its seeds, juice, and peels (Singh et al. Reference Singh, Singh, Kaur and Singh2018). Various phytochemicals, such as alkaloids, tannins, and volatile oils have been found in different parts of pomegranate, which exhibit a wide spectrum of bioactivities, including antiparasitic, antimicrobial, and antioxidant properties (Ge et al. Reference Ge, Duo, Wang, GegenZhula, Yang, Li and Tu2021). Pomegranate peel extract (PGE) has a wide range of therapeutic benefits, including the ability to treat and prevent cancer (Dikmen et al. Reference Dikmen, Ozturk and Ozturk2011), cardiovascular disease (Jurenka, Reference Jurenka2008), and diabetes (Middha et al. Reference Middha, Usha and RaviKiran2012), and improve wound healing (Hayouni et al. Reference Hayouni, Miled, Boubaker, Bellasfar, Abedrabba, Iwaski, Oku, Matsui, Limam and Hamdi2011). Other potential applications include infant brain ischemia, Alzheimer’s disease (Middha et al. Reference Middha, Usha and RaviKiran2012), male infertility, obesity, arthritis (Kanatt et al. Reference Kanatt, Chander and Sharma2010), anthelmintic and anti-protozoan activities (Calzada et al. Reference Calzada, Yépez-Mulia and Aguilar2006 ; El-Sherbini et al. Reference El-Sherbini, El Gozamy, Abdel-Hady and Morsy2009), and antihydatic effects (Labsi et al. Reference Labsi, Khelifi, Mezioug, Soufli and Touil-Boukoffa2016). However, the ultrastructural effect of PGE against cystic echinococcosis has yet to be determined. This study was conducted to determine the in vivo effect of PGE on cystic echinococcosis through parasitological, transmission electron microscopy (TEM), and histopathological studies. Also, serological assessment of serum IFN-γ in mice was measured.

Materials and methods

Parasite

Hydatid cysts were collected from the El-Warrak slaughterhouse in Cairo, Egypt. The protoscoleces (PSCs) were prepared according to Amri et al. (Reference Amri, Aissa, Belguendouz, Mezioug and Touil-Boukoffa2007). Fertile cattle pulmonary cysts were aspirated under aseptic conditions to obtain the hydatid fluid. The fluid was centrifuged, and the sediment containing PSCs was washed with sterile phosphate buffer saline supplemented with 30 mg/mL gentamicin. After being stained with 0.1% eosin, the movement of the PSCs was observed by an inverted microscope to determine their viability. The unstained and moving PSCs were counted as viable. A percentage of viable PSCs of more than 95% was considered suitable for further experimental infection. Each mouse’s infective inoculum was adjusted to contain 2000 viable PSCs suspended in 500 μl of sterile phosphate buffer saline for intraperitoneal inoculation (Urrea-París et al. Reference Urrea-París, Moreno, Casado and Rodriguez-Caabeiro2002).

Experimental animals

The study was carried out on 85 pathogen-free laboratory-bred female albino mice, six to eight weeks old and weighing 24 ± 2 g. They were purchased from the Biology Supply Center at Theodor Bilharz Research Institute (PO Box 30 Imbaba, Giza, Egypt). The mice were housed in standard individual mouse cages (5 mice per cage) in a controlled room temperature (22 ± 1ºC) and humidity, with controlled 12h light/dark cycles and free access to a standard pellet animal diet and tap water. Following the approval of the institutional ethical committee of the National Liver Institute (00507/2023), all animal care and procedures were conducted per international ethical standards.

Tested drugs

ABZ suspension (ABZ 400 mg/10 mL; Pharma Cure Pharmaceuticals Co., Cairo, Egypt) was dissolved in 0.2 mL chromophore L through mechanical shaking and administered orally via a gastric tube at a dose of 200 mg/kg/d for 5 consecutive days per week for 8 weeks starting at 3 months post-infection (Küster et al. Reference Küster, Stadelmann, Aeschbacher and Hemphill2014). The ABZ suspension was shaken vigorously prior to its intragastric delivery to mice. For more clinical efficacy, ABZ formulations were freshly made every 3 days and refrigerated at 3–5°C.

Fresh PGE was prepared by aqueous extraction and then filtered using Whatman filter paper. Mice were treated by daily intragastric administration of 500 μl of PGE. The PGE dose was adjusted to be 0.65 g/kg dissolved in 0.2 ml chromophore L from the second day post-infection (Labsi et al. Reference Labsi, Khelifi, Mezioug, Soufli and Touil-Boukoffa2016).

Experimental design

In the current study, the experimental animals were divided into the following five groups: Group I (5 mice): uninfected and untreated group (normal control); Group II (20 mice): infected untreated group (positive control); Group III (20 mice): infected and treated with ABZ, with treatment started 3 months post-infection; Group IV (20 mice): infected and treated with PGE, with treatment started 3 months post-infection; Group V (20 mice): infected and treated with ABZ and PGE, with treatment started 3 months post-infection. All treatment regimens were continued for 8 weeks, and 1 week after administration of the last dose of the tested drugs, the experiment was terminated. At the end of the study, each mouse was anaesthetized with ether, and blood sampling via a cardiac puncture and sacrifice by cervical dislocation were performed. Blood samples were centrifuged, and sera were separated and stored at -80°C for further serological and biochemical analysis. Each mouse was subjected to parasitological assessment of hydatid cyst size and weight followed by histopathological and TEM examination of the liver tissue and then measurement of serum IFN-γ in all studied groups.

Parasitological assessment

Each mouse’s peritoneal cavity was thoroughly opened during necropsy, and different organs were examined. Digital still photography was used to capture the hydatid cysts, and Adobe Photoshop CS3 (San Francisco, CA, USA) was used to calculate their sizes using the scaled ruler. The cysts were carefully removed, and an analytical balance was used to calculate the weight of the cysts. The following formula was used to calculate the efficacy rate of treatments (Pensel et al. Reference Pensel, Ullio Gamboa, Fabbri, Ceballos, Sanchez Bruni, Alvarez, Allemandi, Benoit, Palma and Elissondo2015). Treatment efficacy= C-T / C X 100%, where C is the mean cyst weight or size in the infected non-treated control group, and T is the mean cyst weight or size in the treated group.

Histopathological examination

Liver tissue samples of each mouse were fixed in 10% formalin, embedded in paraffin, and processed into blocks. Serial sections of 5 μm in thickness were cut and then stained with hematoxylin and eosin (Harries Reference Harries1989). The sections were observed by a light microscope (Olympus BX41, Olympus Corporation, Tokyo, Japan).

Transmission electron microscopy (TEM)

The obtained hydatid cysts were processed as previously reported for ultrastructure examination (Elissondo et al. Reference Elissondo, Dopchiz, Ceballos, Alvarez, Sánchez Bruni, Lanusse and Denegri2006). The samples were photographed by using a JEOLJEM 1230 transmission electron microscope (JEOL, Tokyo, Japan)

Measurement of IFN-γ in mice serum samples

The sandwich ELISA (Quantikine R&D Systems, Inc., Minneapolis, MN, USA) was used to detect IFN-γ in mouse serum samples. Serum samples were examined according to the manufacturer’s recommendations, and IFN-γ concentrations were expressed as pg/mL.

Statistical analysis

Data were tabulated and analysed using SPSS Version 20 (SPSS, IBM, Armonk, USA). The descriptive data were examined by the Chi-square test and Fisher’s exact test. Numerical data were expressed as mean ± standard deviation (SD). The Kruskal-Wallis test was applied and followed by post hoc tests to determine significant differences between groups. Results with P < 0.05 were considered significant.

Results

Parasitological assessment results

In the current study, the highest mortality rate (30%) was observed in the infected control group (GII), but the mortality rate of all treated groups was 15%. The hydatid cyst size and weight declined significantly (P < 0.001) across all treated groups. The smallest hydatid cyst size and weight (0.48 ± 0.47mm, 0.17 ± 0.18 gm) with the highest drug efficacy of 56.2 % was detected in GV, whereas the largest cyst size and weight (1.25 ± 0.85mm, 0.43 ± 0.29 gm) was observed in GIII, with a drug efficacy of 22.9% across treated groups (Table 1).

Table 1. Comparisons between studied groups regarding hydatid cyst size and weight

* Highly significant results: P1 = GIII (ABZ) vs. GII (positive control); P2 = GIV (PGE) vs. GII (positive control); P3 = GV (PGE + ABZ) vs. GII (positive control); P4 = GV (PGE + ABZ) vs. GIII (ABZ).

Histopathological results

In the present study, regarding fibrosis and inflammatory infiltration of liver tissue, there were significant differences between treated groups (GIII, GIV, and GV) and the infected control group (GII) (P < 0.05) (Table 2). Severe fibrosis and inflammatory infiltration of lymphocytes and macrophages in both portal areas and hepatic parenchyma were found in the infected control group (GII) (Figures 1A, B). Improvements were observed in the ABZ (GIII) (Figure 2C) and PGE (GIV) groups, but marked improvements were noticed in the PGE + ABZ group (GV). Evaluation of liver cell necrosis and steatosis (a solitary, sizable lipid vacuole characterises the cytoplasm of hepatocytes) revealed a significant difference between the studied groups (P < 0.05). Therefore, the ABZ group (GII) (Figure 2c) showed the highest values of liver cell necrosis and steatosis. Improvements were reported in PGE + ABZ group (GV) (Figures 2F, G, H). However, the best results were detected in the PGE group (GIV) (Figures 2D, E; Table 2).

Table 2. Comparisons between studied groups regarding histopathological changes in hepatic echinococcosis lesions

Figure 1. Liver sections from E. granulosus-infected groups stained by H & E. GII showing congested central vein (red arrow), inflammatory infiltrate in the form of lymphocytic collection (yellow arrow), and the surrounding hepatocytes showing moderate steatosis (green arrow) (x100) (A) and showing the portal tract with moderate infiltration by lymphocytes (red circle) (x200) (B); GIII exhibiting severe degeneration of liver parenchyma, focal necrosis (yellow arrow), and granulomatous reaction (red arrow) (x40) (C); GIV showing wall of granulomatous reaction with dense fibrosis and scattered cholesterol crystal deposition (green arrow) (x100) (D) and exhibiting severe degeneration of liver parenchyma and frequent cellular apoptosis (red circle) (x100) (E), GV showing granulomatous reaction in the form of collection of lymphocytes, histocytes, and proliferating fibroblasts (black arrow) and fibrosis (red arrow) (x100) (F), congested central vein (black arrow) and moderate infiltration of portal tract by lymphocytes (green arrow) (x 100) (G), scattered degenerated necrotic cells with pyknotic nuclei (red arrow) and scattered apoptotic cells (green arrow) (x200) (H).

Figure 2. Transmission electron micrograph (TEM) of a hydatid cyst (a) from an infected non-treated mouse (GII) showing intact germinal layer (black arrow) and intact laminated layer (red arrow) (×10000); (b) TEM micrograph of hydatid cysts from ABZ treated mouse (GIII) showing auto-phagolysosomes (green arrow), glycogen (red arrow), and cracked nucleus (yellow arrow) (×10000); (c) from PGE treated mouse (GIV) showing the ultrastructure of hydatid cyst with slight disturbance of hydatid layer (black arrow), disturbed cytoplasm (red arrow), and lipid droplets (L) (yellow arrow) (×12000). TEM micrograph of hydatid cysts from PGE + ABZ treated mouse (GV) showing scattered multiple lysosomes (black arrow), scanty glycogen in disturbed vacuolated cytoplasm (yellow arrow), distortion and fragmentation of the nucleus (red arrow) (×12000) (d) (×10000) (e).

Transmission electron microscopy

The ultrastructure of the hydatid cysts retrieved from GII showed an intact germinal layer with microtriches extending into the laminated layer. Also, there were also undifferentiated cells present with intact nuclear membranes and normal nuclei (Figure 2a). The hydatid cysts from the ABZ group (GIII) showed slightly vacuolated cytoplasm, glycogen depletion, and heterochromatin (pyknosis) in the nuclei (Figure 2b). The hydatid cysts obtained from the PGE (Figure 2c) and PGE+ABZ (Figure 2d) groups that showed disturbance of hydatid layers and lipid droplets. The cytoplasm showed fragmentation of the nuclei, glycogen depletion, and multiple lysosomes in vacuolated cytoplasm. All these changes were more obvious in PGE + ABZ group (Figure 2e).

Serum IFN-γ detection results

In the current study, the mean serum concentration of IFN-γ was extremely low (60.28 ± 1.14 pg/ml) in GI. The IFN-γ level was augmented starting in all infected and treated groups. There was a significant difference (P < 0.05) between the studied groups. The highest significant rise was in the ABZ group when compared with GI and GII. Also, there was a significant decrease in serum IFN-γ with PGE treatment either alone (GIV) or combined with ABZ (GV) compared with the infected control (GII) and ABZ (GIII) groups. Combined treatment with PGE + ABZ (GV) showed the most significant reduction in IFN-γ production compared with all the studied groups (P < 0.05) (Figure 3).

Figure 3. Mean values of IFN-γ among the studied groups of experimental animals.

Discussion

Finding novel compounds for the medical treatment of cystic echinococcosis is crucial due to the drawbacks and restrictions of employing benzimidazoles. Punica granatum has garnered significant attention from the public and the academic community due to its potential medicinal properties and relevance to the food industry. The pomegranate fruit exhibits a diverse array of potential therapeutic properties (Shaygannia et al. Reference Shaygannia, Bahmani, Zamanzad and Rafieian-Kopaei2016), and it was recently challenged for its immunomodulatory effect against SARS-CoV-2 (Alexova et al. Reference Alexova, Alexandrova, Dragomanova, Kalfin, Solak, Mehan, Petralia, Fagone, Mangano, Nicoletti and Tancheva2023).

In the current study, the combination of PGE with ABZ gave better results than PGE alone, denoting a synergitic antihydatic effect between these drugs. Similar results regarding PGE were observed by Labsi et al. (Reference Labsi, Khelifi, Mezioug, Soufli and Touil-Boukoffa2016) who found that the diameter and the weight of hydatid cysts were decreased significantly in the PGE group. Thus, they considered it an alternative natural anthelmintic and antimicrobial drug with less toxic effects as the extract is a rich source of phytochemicals that can produce less toxic effects at higher doses or under long-term administration (Moazeni and Roozitalab Reference Moazeni and Roozitalab2012).

The present pathology results denote that PGE treatment associated with ABZ improves the ABZ effect and seems to be more efficient, as reduction of side effects particularly in liver were in agreement with Labsi et al. (Reference Labsi, Soufli, Khelifi, Amir and Touil-Boukoffa2019). In the current study we tried to highlight the ultrastructural alterations induced by PGE in the treatment of cystic echinococcosis, which were in line with findings reported by the use of alternative drugs (Zhang et al. Reference Zhang, Zhou, Su, Zhang, Wang and Liu2017; Yin et al. Reference Yin, Liu, Shen, Zhang and Cao2018). This corroborates the suppressive impact of PGE on E. granulosus cysts. PGE administration resulted in notable alterations in the ultrastructure, specifically disrupting the hydatid layers and lipid droplets. According to Corfield (Reference Corfield2015), the formation of the loose mucus-rich glycogen barriers in the laminated layer was attributed to mucins with a specific type of glycosylation, namely mucin O-type glycosylation (Corfield Reference Corfield2015). The lack of glycogen storage vesicles could be attributed to the influence of combined therapies that actively diminish glucose absorption and storage in hydatid cysts, as elucidated by Lacey’s (Reference Lacey1990) investigation into the impact of the medicinal intervention on the cellular microtubular structures of the metacestode (Lacey Reference Lacey1990). Observing enhanced cellular vacuolisation, swelling of mitochondria, lipid droplets in the germinal layer, and lamellar bodies in the laminated layer may indicate a widespread tissue stress response in reaction to the parasite, potentially leading to apoptosis or necrosis. The process of vacuolisation has the potential to result in significant cytoplasmic content leakage (Kim et al. Reference Kim, Lee, Ryu, Choi and Lee2011). The observation of lipid droplets in the syncytium of the germinal layer may suggest a disturbance in the metabolic processes of the cyst due to therapeutic intervention (Verma et al. Reference Verma, Gangwar, Yashpal and Nath2013).

The assessment of treatment response to a chemotherapeutic agent in cystic echinococcosis is contingent upon multiple factors, one of which is an evaluation of the host immune system response. The immune system’s response to echinococcosis is facilitated by T cells, with Th1 cells capable of generating IFN-γ, IL-2, and lymphotoxin and Th2 cells producing IL-4, IL-6, IL-5, and IL-10. Th1-type responses are deemed pivotal in causing damage to the parasite while augmenting Th2-type responses has a contrary effect (Díaz Reference Díaz2017). The cytokine cascade against parasites has been found to involve IFN-γ, according to earlier studies (Xu et al. Reference Xu, Lu, Dong, Luo, Wang, Liu, Fu, Zhang, Zhu and Ma2017, Zhang et al. Reference Zhang, Wang, Luo, Yuan, Gao, Gao, Song, Shi, Dong and Ma2018). Consistent with these findings, the present study observed a significant elevation in serum IFN-γ levels across all groups relative to the normal control group’s level. The ABZ group exhibited the highest value, followed by the PGE group, with significant reductions observed in serum IFN-γ levels. Earlier studies in experimentally infected mice support these findings; such studies have assumed that an increase in levels of IFN-γ was responsible for damage to formed cysts and included protoscoleces (Rogan Reference Rogan1998). These findings were also in line with those of Riganò et al. (Reference Riganò, Buttari, De Falco, Profumo, Ortona, Margutti, Scottà, Teggi and Siracusano2004) who recoded predominant production of IFN-γ in patients with inactive hydatid cysts. Conversely, patients with cysts active or transitional state displayed an exclusive expression of Th2 cytokines, the authors referred their observation to dependence of immune response on clinical manifestations and the therapeutic intervention’s efficacy (Riganò et al. Reference Riganò, Buttari, De Falco, Profumo, Ortona, Margutti, Scottà, Teggi and Siracusano2004). Shirgholami et al. (Reference Shirgholami, Borji, Mohebalian and Heidarpour2021) also reported a significant increase in levels of IFN-γ concentrations when compared to the control; however, their ABZ group showed the lowest concentration of IFN- γ (Shirgholami et al. Reference Shirgholami, Borji, Mohebalian and Heidarpour2021). We attribute the difference reported in ABZ-treated mice to the duration of infection, administered dose of the drug, and drug regimen.

A significant decrease in the weight of hydatid cysts was observed across all infected treated groups, accompanied by an increase in IFN-γ levels. The protective function of IFN-γ was ascribed to its ability to stimulate peritoneal macrophages and local antibodies that can detect protoscoleces antigens and activate the complement system, removing approximately 90% of the parasite inoculum (Mourglia-Ettlin et al. Reference Mourglia-Ettlin, Marqués, Chabalgoity and Dematteis2011).

Overall, results showed that P. granatum in combination with albendazole had a stronger effect in reducing the hydatid cyst size and weight. The combination also had higher efficacy than either drug alone. Combining ABZ with PGE was most effective in reducing histopathological and ultrastructural changes, with notable reduction in IFN-γ levels. Further studies are recommended to assess immunoregulatory cytokines such as Il-10 and to calculate the ratio of IFN gamma/Il10.

Acknowledgements

We extend our deepest appreciation to Theodor Bilharz Institute veterinary department for all the assistance and technical support they provided during the study.

Financial support

None.

Competing interest

None.

Ethical standard

The study took place under the rules set forth by the Ethical Committee for the handling and using laboratory animals from the National Liver Institute No. 00507/2023.

References

Abdelbaset, AE, Yagi, K, Nonaka, N, Nakao, R (2021). Cystic echinococcosis in humans and animals in Egypt: An epidemiological overview. Current Research in Parasitology & Vector-Borne Diseases 1, 100061. https://doi.org/10.1016/j.crpvbd.2021.100061CrossRefGoogle ScholarPubMed
Alexova, R, Alexandrova, S, Dragomanova, S, Kalfin, R, Solak, A, Mehan, S, Petralia, M C, Fagone, P, Mangano, K, Nicoletti, F, Tancheva, L (2023). Anti-COVID-19 potential of ellagic acid and polyphenols of Punica granatum L. Molecules 28, 3772. https://doi.org/10.3390/molecules28093772CrossRefGoogle ScholarPubMed
Amri, M, Aissa, SA, Belguendouz, H, Mezioug, D, Touil-Boukoffa, C (2007). In vitro antihydatic action of IFN-gamma is dependent on the nitric oxide pathway. Journal of Interferon & Cytokine Research 27, 781787. https://doi.org/10.1089/jir.2007.0003CrossRefGoogle ScholarPubMed
Atayi, Z, Borji, H, Moazeni, M, Saboor Darbandi, M, Heidarpour, M (2018). Zataria multiflora would attenuate the hepatotoxicity of long-term albendazole treatment in mice with cystic echinococcosis. Parasitology International 67, 184187. https://doi.org/10.1016/j.parint.2017.11.007CrossRefGoogle ScholarPubMed
Calzada, F, Yépez-Mulia, L, Aguilar, A (2006). In vitro susceptibility of Entamoeba histolytica and Giardia lamblia to plants used in Mexican traditional medicine for the treatment of gastrointestinal disorders. Journal of Ethnopharmacology 108, 367370. https://doi.org/10.1016/j.jep.2006.05.025CrossRefGoogle ScholarPubMed
Corfield, A P (2015). Mucins: A biologically relevant glycan barrier in mucosal protection. Biochimica et Biophysica Acta 1850, 236252. https://doi.org/10.1016/j.bbagen.2014.05.003CrossRefGoogle ScholarPubMed
Díaz, Á (2017). Immunology of cystic echinococcosis (hydatid disease). British Medical Bulletin 124, 121133. https://doi.org/10.1093/bmb/ldx033.Google ScholarPubMed
Dikmen, M, Ozturk, N, Ozturk, Y (2011). The antioxidant potency of Punica granatum L. Fruit peel reduces cell proliferation and induces apoptosis on breast cancer. Journal of Medicinal Food 14, 16381646. https://doi.org/10.1089/jmf.2011.0062CrossRefGoogle ScholarPubMed
El-Sherbini, GT, El Gozamy, BR, Abdel-Hady, NM, Morsy, TA (2009). Efficacy of two plant extracts against vaginal trichomoniasis. Journal of the Egyptian Society of Parasitology 39, 4758.Google ScholarPubMed
Elissondo, M, Dopchiz, M, Ceballos, L, Alvarez, L, Sánchez Bruni, S, Lanusse, C, Denegri, G (2006). In vitro effects of flubendazole on Echinococcus granulosus protoscoleces. Parasitology Research 98, 317323. https://doi.org/10.1007/s00436-005-0026-6CrossRefGoogle ScholarPubMed
Ge, S, Duo, L, Wang, J, GegenZhula, , Yang, J, Li, Z, Tu, Y (2021). A unique understanding of traditional medicine of pomegranate, Punica granatum L. and its current research status. Journal of Ethnopharmacology 271, 113877. https://doi.org/10.1016/j.jep.2021.113877CrossRefGoogle ScholarPubMed
Harries, ML (1989). Carleton’s Histopathological Technique. New York, Toronto: Oxford University Press.Google Scholar
Hayouni, EA, Miled, K, Boubaker, S, Bellasfar, Z, Abedrabba, M, Iwaski, H, Oku, H, Matsui, T, Limam, F, Hamdi, M (2011). Hydroalcoholic extract based-ointment from Punica granatum L. peels with enhanced in vivo healing potential on dermal wounds. Phytomedicine 18, 976984. https://doi.org/10.1016/j.phymed.2011.02.011CrossRefGoogle ScholarPubMed
Heidarpour, M, Mohri, M, Borji, H, Moghdass, E (2012). Oxidative stress and trace elements in camel (Camelus dromedarius) with liver cystic echinococcosis. Veterinary Parasitology 187, 459463. https://doi.org/10.1016/j.vetpar.2012.01.015CrossRefGoogle ScholarPubMed
Jelowdar, A, Rafiei, A, Abbaspour, MR, Rashidi, I, Rahdar, M (2017). Efficacy of combined albendazol and praziquntel and their loaded solid lipid nanoparticles components in chemoprophylaxis of experimental hydatidosis. Asian Pacific Journal of Tropical Biomedicine 7, 549554. https://doi.org/10.1016/j.apjtb.2017.05.011CrossRefGoogle Scholar
Jurenka, JS (2008). Therapeutic applications of pomegranate (Punica granatum L.): a review. Alternative Medicine Review 13, 128144.Google ScholarPubMed
Kanatt, SR, Chander, R, Sharma, A (2010). Antioxidant and antimicrobial activity of pomegranate peel extract improves the shelf life of chicken products. International Journal of Food Science & Technology 45, 216222. https://doi.org/10.1111/j.1365-2621.2009.02124.xCrossRefGoogle Scholar
Kern, P, Menezes da Silva, A, Akhan, O, Müllhaupt, B, Vizcaychipi, KA, Budke, C, Vuitton, DA (2017). The Echinococcoses: Diagnosis, clinical management and burden of disease. Advances in Parasitology 96, 259369. https://doi.org/10.1016/bs.apar.2016.09.006CrossRefGoogle ScholarPubMed
Kim, S-H, Lee, H-S, Ryu, D-S, Choi, S-J, Lee, D-S (2011). Antibacterial activity of silver-nanoparticles against Staphylococcus aureus and Escherichia coli. Microbiology and Biotechnology Letters 39, 7785.Google Scholar
Küster, T, Stadelmann, B, Aeschbacher, D, Hemphill, A (2014). Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model. International Journal of Antimicrobial Agents 43, 335342. https://doi.org/10.1016/j.ijantimicag.2014.01.013CrossRefGoogle Scholar
Labsi, M, Khelifi, L, Mezioug, D, Soufli, I, Touil-Boukoffa, C (2016). Antihydatic and immunomodulatory effects of Punica granatum peel aqueous extract in a murine model of echinococcosis. Asian Pacific Journal of Tropical Medicine 9, 211220. https://doi.org/10.1016/j.apjtm.2016.01.038CrossRefGoogle Scholar
Labsi, M, Soufli, I, Khelifi, L, Amir, ZC, Touil-Boukoffa, C (2019). A preventive effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: An alternative approach. Acta Tropica 197, 105050. https://doi.org/10.1016/j.actatropica.2019.105050CrossRefGoogle ScholarPubMed
Lacey, E (1990). Mode of action of benzimidazoles. Parasitology Today 6, 112115. https://doi.org/10.1016/0169-4758(90)90227-uCrossRefGoogle ScholarPubMed
Mahmoudi, S, Mamishi, S, Banar, M, Pourakbari, B, Keshavarz, H (2019). Epidemiology of echinococcosis in Iran: A systematic review and meta-analysis. BMC Infectious Diseases 19, 929. https://doi.org/10.1186/s12879-019-4458-5CrossRefGoogle ScholarPubMed
Middha, SK, Usha, T, RaviKiran, T (2012). Influence of Punica granatum L. on region specific responses in rat brain during Alloxan-Induced diabetes. Asian Pacific Journal of Tropical Biomedicine 2, S905S909. https://doi.org/10.1016/S2221-1691(12)60334-7CrossRefGoogle Scholar
Moazeni, M, Roozitalab, A (2012). High scolicidal effect of Zataria multiflora on protoccoleces of hydatid cyst: an in vitro study. Comparative Clinical Pathology 21, 99104. https://doi.org/10.1007/s00580-010-1069-3CrossRefGoogle Scholar
Mourglia-Ettlin, G, Marqués, JM, Chabalgoity, JA, Dematteis, S (2011). Early peritoneal immune response during Echinococcus granulosus establishment displays a biphasic behavior. PLoS Neglected Tropical Diseases 5, e1293. https://doi.org/10.1371/journal.pntd.0001293CrossRefGoogle ScholarPubMed
Pensel, PE, Ullio Gamboa, G, Fabbri, J, Ceballos, L, Sanchez Bruni, S, Alvarez, LI, Allemandi, D, Benoit, JP, Palma, SD, Elissondo, MC (2015). Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Tropica 152, 185194. https://doi.org/10.1016/j.actatropica.2015.09.016CrossRefGoogle ScholarPubMed
Riganò, R, Buttari, B, De Falco, E, Profumo, E, Ortona, E, Margutti, P, Scottà, C, Teggi, A, Siracusano, A (2004). Echinococcus granulosus-specific T-cell lines derived from patients at various clinical stages of cystic echinococcosis. Parasite Immunology 26, 4552. https://doi.org/10.1111/j.0141-9838.2004.00682.xCrossRefGoogle ScholarPubMed
Rogan, MT (1998). T-cell activity associated with secondary infections and implanted cysts of Echinococcus granulosus in BALB/c mice. Parasite Immunology 20, 527533. https://doi.org/10.1046/j.1365-3024.1998.00180.xCrossRefGoogle ScholarPubMed
Shaygannia, E, Bahmani, M, Zamanzad, B, Rafieian-Kopaei, M (2016). A review study on Punica granatum L. Journal of Evidence-Based Complementary & Alternative Medicine 21, 221227. https://doi.org/10.1177/2156587215598039CrossRefGoogle Scholar
Shi, H, Lei, Y, Wang, B, Wang, Z, Xing, G, Lv, H, Jiang, Y (2016). Protoscolicidal effects of chenodeoxycholic acid on protoscoleces of Echinococcus granulosus. Experimental Parasitology 167, 7682. https://doi.org/10.1016/j.exppara.2016.05.004CrossRefGoogle ScholarPubMed
Shirgholami, Z, Borji, H, Mohebalian, H, Heidarpour, M (2021). Effects of Allium sativum on IFN-γ and IL4 concentrations in mice with cystic echinococcosis. Experimental Parasitology 220, 108042. https://doi.org/10.1016/j.exppara.2020.108042CrossRefGoogle ScholarPubMed
Siles-Lucas, M, Casulli, A, Cirilli, R, Carmena, D (2018). Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets. PLoS Neglected Tropical Diseases 12, e0006422. https://doi.org/10.1371/journal.pntd.0006422CrossRefGoogle ScholarPubMed
Singh, B, Singh, JP, Kaur, A, Singh, N (2018). Phenolic compounds as beneficial phytochemicals in pomegranate (Punica granatum L.) peel: A review. Food Chemistry 261, 7586. https://doi.org/10.1016/j.foodchem.2018.04.039CrossRefGoogle ScholarPubMed
Urrea-París, M, Moreno, M, Casado, N, Rodriguez-Caabeiro, F (2002). Relationship between the efficacy of praziquantel treatment and the cystic differentiation in vivo of Echinococcus granulosus metacestode. Parasitology Research 88, 2631. https://doi.org/10.1007/s004360100468CrossRefGoogle ScholarPubMed
Verma, VC, Gangwar, M, Yashpal, M, Nath, G (2013). Anticestodal activity of endophytic Pestalotiopsis sp. on protoscoleces of hydatid cyst Echinococcus granulosus. BioMed Research International 2013, 308515. https://doi.org/10.1155/2013/308515CrossRefGoogle ScholarPubMed
Wen, H, Vuitton, L, Tuxun, T, Li, J, Vuitton, DA, Zhang, W, McManus, DP (2019). Echinococcosis: Advances in the 21st Century. Clinical Microbiology Reviews 32, e0007518. https://doi.org/10.1128/CMR.00075-18CrossRefGoogle ScholarPubMed
WHO (2022). Ending the Neglect to Attain the Sustainable Development Goals: A Rationale for Continued Investment in Tackling Neglected Tropical Diseases 2021–2030. Geneva: World Health Organization.Google Scholar
Xu, X, Lu, X, Dong, X, Luo, Y, Wang, Q, Liu, X, Fu, J, Zhang, Y, Zhu, B, Ma, X (2017). Effects of hMASP-2 on the formation of BCG infection-induced granuloma in the lungs of BALB/c mice. Scientific Reports 7, 2300. https://doi.org/10.1038/s41598-017-02374-zCrossRefGoogle ScholarPubMed
Yin, J, Liu, C, Shen, Y, Zhang, H, Cao, J (2018). Efficacy of ursolic acid against Echinococcus granulosus in vitro and in a murine infection model. Parasites & Vectors 11, 58. https://doi.org/10.1186/s13071-018-2628-8CrossRefGoogle Scholar
Zhang, G, Wang, J, Luo, Y, Yuan, M, Gao, Q, Gao, H, Song, X, Shi, Y, Dong, K, Ma, X (2018). In vivo evaluation of the efficacy of Sophora moorcroftiana alkaloids in combination with Bacillus Calmette-Guérin (BCG) treatment for cystic echinococcosis in mice. Journal of Helminthology 92, 681686. https://doi.org/10.1017/S0022149X1700089XCrossRefGoogle ScholarPubMed
Zhang, S, Zhou, Y, Su, L, Zhang, X, Wang, H, Liu, B (2017). In vivo evaluation of the efficacy of combined albedazole-IFN-α treatment for cystic echinococcosis in mice. Parasitology Research 116, 735742. https://doi.org/10.1007/s00436-016-5339-0CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Comparisons between studied groups regarding hydatid cyst size and weight

Figure 1

Table 2. Comparisons between studied groups regarding histopathological changes in hepatic echinococcosis lesions

Figure 2

Figure 1. Liver sections from E. granulosus-infected groups stained by H & E. GII showing congested central vein (red arrow), inflammatory infiltrate in the form of lymphocytic collection (yellow arrow), and the surrounding hepatocytes showing moderate steatosis (green arrow) (x100) (A) and showing the portal tract with moderate infiltration by lymphocytes (red circle) (x200) (B); GIII exhibiting severe degeneration of liver parenchyma, focal necrosis (yellow arrow), and granulomatous reaction (red arrow) (x40) (C); GIV showing wall of granulomatous reaction with dense fibrosis and scattered cholesterol crystal deposition (green arrow) (x100) (D) and exhibiting severe degeneration of liver parenchyma and frequent cellular apoptosis (red circle) (x100) (E), GV showing granulomatous reaction in the form of collection of lymphocytes, histocytes, and proliferating fibroblasts (black arrow) and fibrosis (red arrow) (x100) (F), congested central vein (black arrow) and moderate infiltration of portal tract by lymphocytes (green arrow) (x 100) (G), scattered degenerated necrotic cells with pyknotic nuclei (red arrow) and scattered apoptotic cells (green arrow) (x200) (H).

Figure 3

Figure 2. Transmission electron micrograph (TEM) of a hydatid cyst (a) from an infected non-treated mouse (GII) showing intact germinal layer (black arrow) and intact laminated layer (red arrow) (×10000); (b) TEM micrograph of hydatid cysts from ABZ treated mouse (GIII) showing auto-phagolysosomes (green arrow), glycogen (red arrow), and cracked nucleus (yellow arrow) (×10000); (c) from PGE treated mouse (GIV) showing the ultrastructure of hydatid cyst with slight disturbance of hydatid layer (black arrow), disturbed cytoplasm (red arrow), and lipid droplets (L) (yellow arrow) (×12000). TEM micrograph of hydatid cysts from PGE + ABZ treated mouse (GV) showing scattered multiple lysosomes (black arrow), scanty glycogen in disturbed vacuolated cytoplasm (yellow arrow), distortion and fragmentation of the nucleus (red arrow) (×12000) (d) (×10000) (e).

Figure 4

Figure 3. Mean values of IFN-γ among the studied groups of experimental animals.